CURRICULUM VITAE MARK DAVID SANCHEZ, MD, FACOG 2454 McMullen Booth Rd., Suite 601 Phone: (727) 796­7705 CURRENT POSITIONS Reproductive Endocrinologist IVF Medical Director Florida Fertility Institute Clearwater, Florida Associate Medical Director and Investigator Women's Medical Research Group, LLC Clearwater, Florida Associate Medical Director and Investigator Florida Clinical Research Group Clearwater, Florida Department Chair Obstetrics and Gynecology Bayfront Medical Center St. Petersburg, Florida BIRTH DATE and PLACE March 25, 1969, Indianapolis, IN EDUCATION and TRAINING 1999­2002 Fellowship in Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology University of South Florida Tampa, Florida 1995­1999 Obstetrics and Gynecology Residency Department of Obstetrics and Gynecology Bayfront Medical Center St. Petersburg, Florida 1991­1995 Doctor of Medicine University of Florida College of Medicine Gainesville, Florida 1989­1991 Bachelor of Science Major: Biology Minor: History University of South Florida Tampa, Florida WORK EXPERIENCE 2002­2014 Reproductive Endocrinologist IVF Medical Director Florida Fertility Institute Clearwater, Florida 2003­2014 Associate Medical Director and Investigator Women's Medical Research Group, LLC Clearwater, Florida 2003­2014 Associate Medical Director and Investigator Florida Clinical Research Group Clearwater, Florida LICENSES, CERTIFICATIONS, AND EXAMINATIONS 1996 Florida Medical License (Active) 2005 Board Certified Reproductive Endocrinology and Infertility 2004 Board Certified American Board of Obstetrics and Gynecology 1995 Advanced Cardiac Life Support (ACLS) , Recertified YEAR (Active) 1995 Basic Life Support (BLS), Recertified YEAR (Active) PROFESSIONAL AFFILIATIONS American College of Obstetrics and Gynecology, Fellow American Society for Reproductive Medicine, Full Member American Society for Colposcopy and Cervical Pathology, Member American Association of Gynecologic Laparoscopists, Member Society for Reproductive Endocrinology and Infertility, Full Member PROFESSIONAL APPOINTMENTS 2012­2014 Department Chair Obstetrics and Gynecology Bayfront Medical Center St. Petersburg, Florida 2012­2014 Medical Council Member Bayfront Medical Center St. Petersburg, Florida 2012­2014 Standards and Credential Committee Bayfront Medical Center St. Petersburg, Florida 2010­2012 Quality Improvement Chair Department of Obstetrics and Gynecology Bayfront Medical Center St. Petersburg, Florida 2010­2012 Department Vice­Chair Obstetrics and Gynecology Bayfront Medical Center St. Petersburg, Florida 2001­2002 Peer Review Committee Department of Obstetrics and Gynecology University of South Florida Tampa, Florida 1999­2002 Residency Selection Committee Department of Obstetrics and Gynecology University of South Florida Tampa, Florida 1998­1999 Chief Administrative Resident Department of Obstetrics and Gynecology Bayfront Medical Center St. Petersburg, Florida 1998­1999 Residency Selection Committee Department of Obstetrics and Gynecology Bayfront Medical Center St. Petersburg, Florida 1997­1999 Process Improvement Team Department of Obstetrics and Gynecology Bayfront Medical Center St. Petersburg, Florida 1997­1999 Quality Assurance Committee Department of Obstetrics and Gynecology Bayfront Medical Center St. Petersburg, Florida 1995­1999 Medical Education Committee Bayfront Medical Center St. Petersburg, Florida 1995­1999 Library Committee Bayfront Medical Center St. Petersburg, Florida AWARDS AND HONORS 2013 Chief Residents’ Special Recognition Award, Department of Obstetrics and Gynecology, Bayfront Medical Center 2006 Attending of the Year July 2000­June 2001, Department of Obstetrics and Gynecology, Bayfront Medical Center 2002 Attending of the Year July 2000­June 2001, Department of Obstetrics and Gynecology, Bayfront Medical Center 2001 Attending of the Year July 2000­June 2001, Department of Obstetrics and Gynecology, Bayfront Medical Center 2001 Postdoctoral Grant Recipient Florida/Puerto Rico Regional, American Heart Association for paper entitled: Regulation of the High Density Lipoprotein Receptor by Estradiol 1999 Excellence in Colposcopy and the Treatment of Lower Genital Tract Disease Award, The American Society for Colposcopy and Cervical Pathology 1999 Excellence in Endoscopic Procedures, The American Association of Gynecologic Laparoscopists 1999 Outstanding Research in Women's Health, Organon Resident Research Award 1998 Outstanding Research in Endometriosis, Resident Research Award, Bayfront Medical Center 1994 Outstanding Leadership, University of Florida, College of Medicine 1993 Recipient, Minority Affairs Dean's Scholarship, University of Florida, College of Medicine 1990 Academic Excellence Honors Convocation, University of South Florida PEER­REVIEWED PUBLICATIONS Hirth R, Zbella E, Sanchez M, Prieto J. Microtubal reanastomosis: success rates as compared to in vitro fertilization. J Reprod Med. 2010 Mar­Apr;55(3­4):161­5. Lopez D, Sanchez MD, Shea­Eaton W, McLean MP. Estrogen activates the high­density lipoprotein receptor gene via binding to estrogren response elements and interaction with sterol regulatory element binding protein­1A. Endocrinology. 2002 Jun;143(6):2155­68. Lopez D, Shea­Eaton W, Sanchez MD, McLean MP. DAX­1 represses the high­density lipoprotein receptor through interaction with positive regulators sterol regulatory element­binding protein­1a and steroidgenic factor­1. Endocrinology. 2001 Dec; 142(12):5097­106. ABSTRACTS 1. S. Tubens, M. Sanchez, E. Zbella, J. Steele.Pregnancy: tubooclusive vs. standard ligation reversal. Fertility and Sterility Vol. 100, Issue 3, Supplement, Page S173 CLINICAL RESEARCH TRIALS Ongoing Clinical Studies Sponsor: Nora Therapeutics, Inc Protocol: NT­03 Title: A Randomized, Double­Blind, Multi­Center, Placebo­Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Multiple Doses of NT100 Following In Vitro­Fertilization (IVF) in Women with a History of Repeated IVF Failure (Thrive­IVF) Site PI: Edward Zbella, M.D., CPI Role: Sub­Investigator Sponsor: NovaDigm Therapeutics, Inc Protocol: NDV3A­003 Title: A Phase 1b/2a, Multi­center, Double­blind, Randomized, Placebo­controlled Study to Evaluate the Safety, Tolerability, Immunogenicity and Efficacy in Preventing Vulvovaginal Candidiasis in Subjects with Recurrent Vulvovaginal Candidiasis Following Administration of a Single Dose of NDV­3A Vaccine, NDV­3 Vaccine or Placebo Site PI: Edward Zbella, M.D., CPI Role: Sub­Investigator Sponsor: Abbott Laboratories Protocol: M12­665 Title: A Randomized, Double­Blind, Placebo­Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis­Associated Pain Site PI: Mark Sanchez, M.D. Role: Principal Investigator Sponsor: Repros Therapeutics, Inc. Protocol: ZPE­202 Title: A Phase 2, Multi­Center, Three –Arm, Parrallel Designed, Randomized, Double­Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women with Endometriosis Confirmed Within the Last Five Years and Who are Currently Using Narcotic For Control of Symptomatic Pain Site PI: Edward Zbella, M.D., CPI Role: Sub­Investigator Sponsor: Repros Therapeutics, Inc. Protocol: ZA­301 ext. Title: An Open Label, 6 Month Phase III Extension Study of Enclomiphene Citrate in the Treatment of Men with Secondary Hypogonadism Site PI: Edward Zbella, M.D., CPI Role: Sub­Investigator Clinical Studies Completed in 2013 Sponsor: Agility Clinical Protocol: TET2013­001A Title: A Multicenter, 26­Week, Prospective, Observational Study In Adult Patients With Prediabetes Assessing The Impact Of The PreDx Test On Patient Treatment And Outcomes In Community­Based Clinical Practices Site PI: Edward Zbella, M.D., CPI Role: Sub­Investigator Sponsor: Teva Pharmaceuticals Industries, Ltd. Protocol: 71036006 Title: Randomized, Investigator­Blind, Placebo­Controlled, Parallel Design, Multiple­Site Study Comparing TEVA Pharmaceuticals Estradiol Vaginal Tablets with Vagifem® (Estradiol) Vaginal Tablets (Novo Nordisk) in the Treatment of Atrophic Vaginitis Site PI: Edward Zbella, M.D., CPI Role: Sub­Investigator Sponsor: Warner Chilcott, LLC Protocol: PR­08112 Title: A Randomized, Multicenter, Double­Blind, Vehicle­Controlled Study to Evaluate the Safety and Efficacy of WC3011 in Postmenopausal Women with Dyspareunia Site PI: Edward Zbella, M.D., CPI Role: Sub­Investigator Sponsor: Warner Chilcott, LLC Protocol: PR­05812 Title: A Randomized, Multicenter, Double­Blind, Vehicle­Controlled Study to Evaluate the Safety and Efficacy of WC3011 in Postmenopausal Women. Site PI: Edward Zbella, M.D., CPI Role: Sub­Investigator Sponsor: Repros Therapeutics Inc. Protocol: ZA­301 Title: A Randomized, Double Blind, Placebo Controlled Multi Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men with Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration Site PI: Edward Zbella, M.D., CPI Role: Sub­Investigator Sponsor: Repros Therapeutics Inc. Protocol: ZA­300 Title: An Open­Label, Escalating Dose, 6­Month Phase III Safety Study of Enclomiphene Citrate in the Treatment Of Men with Secondary Hypogonadism Site PI: Edward Zbella, M.D., CPI Role: Sub­Investigator Sponsor: Medicis Pharmaceutical Corp Protocol: MP­1601­01 Title: A Phase III, Multi­Center, Randomized, Doubl Blind, Vehicle­Controlled Study to Evaluate the Safety and Efficacy of Product 55394 in the Treatment of (BV) Bacterial Vaginosis